NHS South of England Branded Medicines - Tranche A - September 2023

NHS South of England Branded Medicines - Tranche A - September 2023

Offer reference number: CM/PHR/22/5676

CM/PHR/22/5676/01 - NHS Framework for South of England Branded Medicines - Tranche A. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5676/02 - NHS Framework for South of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

CM/PHR/22/5676/03 - NHS Framework Agreement for the supply of Risankizumab for the Midlands & East and North of England. Period of framework: 1 September 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.